Comment
doi: 10.1016/S0140-6736(14)62259-5.
Epub 2015 May 19.
Neoadjuvant chemotherapy for ovarian cancer: do we have enough evidence?
Affiliations
- PMID: 26002110
- DOI: 10.1016/S0140-6736(14)62259-5
Item in Clipboard
Comment
Neoadjuvant chemotherapy for ovarian cancer: do we have enough evidence?
Lancet.
.
No abstract available
Comment on
-
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.Lancet. 2015 Jul 18;386(9990):249-57. doi: 10.1016/S0140-6736(14)62223-6. Epub 2015 May 19. Lancet. 2015. PMID: 26002111 Clinical Trial.
Similar articles
-
Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusion.Oncology (Williston Park). 2008 Nov 30;22(13):1456; author reply 1456-7. Oncology (Williston Park). 2008. PMID: 19133602 No abstract available.
-
Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer.Gynecol Oncol. 2007 Jul;106(1):273-4; author reply 274-5. doi: 10.1016/j.ygyno.2007.03.013. Epub 2007 Apr 30. Gynecol Oncol. 2007. PMID: 17467780 No abstract available.
-
LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).Gynecol Oncol. 2004 Mar;92(3):1017-8; author reply 1018-9. doi: 10.1016/j.ygyno.2003.11.050. Gynecol Oncol. 2004. PMID: 14984983 No abstract available.
-
[Neoadjuvant chemotherapy in the treatment of ovarian cancer].Orv Hetil. 2005 Sep 18;146(38):1951-5. Orv Hetil. 2005. PMID: 16238247 Review. Hungarian.
-
[Ovarian cancer from the standpoint of medical oncology].Gan To Kagaku Ryoho. 2007 Jul;34(7):1017-21. Gan To Kagaku Ryoho. 2007. PMID: 17637538 Review. Japanese.
Cited by
-
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.J Gynecol Oncol. 2020 Jan;31(1):e17. doi: 10.3802/jgo.2020.31.e17. J Gynecol Oncol. 2020. PMID: 31833259 Free PMC article.
-
Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer.ESMO Open. 2021 Jun;6(3):100149. doi: 10.1016/j.esmoop.2021.100149. Epub 2021 May 10. ESMO Open. 2021. PMID: 33984680 Free PMC article. Review.
-
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol. 2016 Oct 1;34(28):3460-73. doi: 10.1200/JCO.2016.68.6907. Epub 2016 Aug 8. J Clin Oncol. 2016. PMID: 27502591 Free PMC article.
-
Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?Ann Surg Oncol. 2021 Jul;28(7):3605-3615. doi: 10.1245/s10434-020-09304-w. Epub 2020 Nov 5. Ann Surg Oncol. 2021. PMID: 33155151
-
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.Gynecol Oncol. 2016 Oct;143(1):3-15. doi: 10.1016/j.ygyno.2016.05.022. Epub 2016 Aug 8. Gynecol Oncol. 2016. PMID: 27650684 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
